Related Experiment Video
Updated: Aug 7, 2026
An Orthotopic Bladder Tumor Model and the Evaluation of Intravesical saRNA Treatment
Published on: July 28, 2012
Reverse transcriptase inhibitors and chemically induced bladder tumors in mice
Abstract:
Recent immunologic and microbiologic evidence suggests that urothelial tumors may be caused by "C" type oncogenic viruses. Such viruses may exert their oncogenic potential in responce to stimulation by known chemical carcinogens. By means of a unique enzyme, reverse transcriptase, these viruses are able to incorporate genetic information into that of the host, and can thereby be transmitted vertically from generation to generation. An evaluation of the specific antiviral agents dimethylbenzyldemethl-rifampicin and streptovaricin-comples, which inhibit the enzyme reverse transcriptase, revealed no depay in the induction of bladder tumors by the chemical carcinogen, 2-formylamino-4-(5-nitro-2-furyl) thiazole (FANFT) in C3H mice. This observation suggests that the reproduction and release of virus may not be essential in the malignant transformation of bladder epithelial cells, but does not preclude the possiblity that inherited viral genetic information may be involved in the oncogenesis of bladder tumors.
Insights
Oncogenic viruses may contribute to bladder cancer. Antiviral drugs targeting reverse transcriptase did not prevent tumors, suggesting viral reproduction isn't essential for malignant transformation.
Area of Science:
- Oncology
- Virology
- Carcinogenesis
Background:
- Urothelial tumors (bladder cancer) may be linked to specific oncogenic viruses.
- These viruses might act with chemical carcinogens to promote cancer.
- Viral reverse transcriptase enables genetic incorporation into host cells, allowing vertical transmission.
Purpose of the Study:
- To investigate the role of viral reverse transcriptase in chemical carcinogen-induced bladder tumors.
- To determine if inhibiting reverse transcriptase affects bladder tumor development.
Main Methods:
- Mice (C3H) were administered a chemical carcinogen, 2-formylamino-4-(5-nitro-2-furyl) thiazole (FANFT).
- Specific antiviral agents (dimethylbenzyldemethl-rifampicin and streptovaricin-comples) targeting reverse transcriptase were administered.
- Tumor induction rates and timing were monitored.
Main Results:
- Inhibition of reverse transcriptase did not delay the induction of bladder tumors by FANFT.
- Viral reproduction and release were not essential for malignant transformation in this model.
Conclusions:
- While viral reproduction may not be critical, inherited viral genetic information could still play a role in bladder cancer oncogenesis.
- Further research is needed to explore the potential involvement of latent viral genetic material in urothelial tumor development.
